DME Treatment Strategies With Longer Duration Therapies
Carl J. Danzig, MD and John W. Kitchens, MD, discuss two case studies, including a treatment-naïve patient with proliferative diabetic retinopathy and diabetic macular edema and a patient with a long history of anti-VEGF injections who was switched to aflibercept 8 mg. This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc. Click here to view the webinar event, which includes images from the talk. Check out the central hub of this webinar series. Want to register with Evolve Medical Education? Click here.